The medicinal chemistry of therapeutic oligonucleotides

WB Wan, PP Seth - Journal of medicinal chemistry, 2016 - ACS Publications
Oligonucleotide-based therapeutics have made rapid progress in the clinic for treatment of a
variety of disease indications. Unmodified oligonucleotides are polyanionic macromolecules …

Three's a crowd–stabilisation, structure, and applications of DNA triplexes

M Dalla Pozza, A Abdullrahman, CJ Cardin… - Chemical …, 2022 - pubs.rsc.org
DNA is a strikingly flexible molecule and can form a variety of secondary structures,
including the triple helix, which is the subject of this review. The DNA triplex may be formed …

Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications

A Aartsma-Rus, GJB Van Ommen - Rna, 2007 - rnajournal.cshlp.org
Antisense-mediated modulation of splicing is one of the few fields where antisense
oligonucleotides (AONs) have been able to live up to their expectations. In this approach …

An overview of sugar‐modified oligonucleotides for antisense therapeutics

TP Prakash - Chemistry & biodiversity, 2011 - Wiley Online Library
Among the multitude of chemical modifications that have been described over the past two
decades, oligonucleotide analogs that are modified at the 2′‐position of the furanose sugar …

Synthesis and Biophysical Evaluation of 2′,4′-Constrained 2′O-Methoxyethyl and 2′,4′-Constrained 2′O-Ethyl Nucleic Acid Analogues

PP Seth, G Vasquez, CA Allerson… - The Journal of …, 2010 - ACS Publications
We have recently shown that combining the structural elements of 2′ O-methoxyethyl
(MOE) and locked nucleic acid (LNA) nucleosides yielded a series of nucleoside …

Development of nucleic acid medicines based on chemical technology

Y Kawamoto, Y Wu, Y Takahashi, Y Takakura - Advanced Drug Delivery …, 2023 - Elsevier
Oligonucleotide-based therapeutics have attracted attention as an emerging modality that
includes the modulation of genes and their binding proteins related to diseases, allowing us …

Nucleoside and oligonucleotide analogues

M Kaneko, K Morita, T Imanishi - US Patent 7,314,923, 2008 - Google Patents
US7314923B2 - Nucleoside and oligonucleotide analogues - Google Patents
US7314923B2 - Nucleoside and oligonucleotide analogues - Google Patents Nucleoside …

Oligoribonucleotides and ribonucleases for cleaving RNA

ST Crooke - US Patent 7,695,902, 2010 - Google Patents
Oligomeric compounds including oligoribonucleotides and oligoribonucleosides are
provided that have subsequences of 2'-pentoribofuranosyl nucleosides that activate …

Antisense drug discovery and development

T Yamamoto, M Nakatani, K Narukawa… - Future medicinal …, 2011 - Future Science
Numerous chemically modified oligonucleotides have been developed so far and show their
own unique chemical properties and pharmacodynamic/pharmacokinetic characteristics …

Nucleoside and oligonucleotide analogues

M Kaneko, K Morita, T Imanishi - US Patent 7,335,765, 2008 - Google Patents
3,687,808 A 8, 1972 Merigan, Jr. et al. 4,689,320 A 8/1987 Kaji 4,806.463. A 2f1989
Goodchild et al. 5,004,810 A 4/1991 Draper 5,166,195 A 11/1992 Ecker 5, 194428 A 3/1993 …